Evidence map›Paper›PMID 40496349›Full record

ArticleFASEB bioAdvances2025

Netrin-4 Modulates Corneal Wound Healing by Enhancing Corneal Epithelium and Nerve Regeneration.

Cissy Xiao, Daniel Lara-Newman, Qiang Zhou, Mark I Rosenblatt, Victor H Guaiquil

Abstract read
In one paragraph

Article in FASEB bioAdvances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cissy XiaoDepartment of Ophthalmology and Visual Sciences University of Illinois-Chicago Chicago Illinois USA.
Daniel Lara-NewmanDepartment of Ophthalmology and Visual Sciences University of Illinois-Chicago Chicago Illinois USA.
Qiang ZhouDepartment of Ophthalmology and Visual Sciences University of Illinois-Chicago Chicago Illinois USA.
Mark I RosenblattDepartment of Ophthalmology and Visual Sciences University of Illinois-Chicago Chicago Illinois USA.
Victor H GuaiquilDepartment of Ophthalmology and Visual Sciences University of Illinois-Chicago Chicago Illinois USA.ORCID https://orcid.org/0000-0003-0429-7692

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCANANY, JAMES JASON · 1985 to 2025
$14.8M
Mechanisms of Corneal Nerve RepairR01EY027912 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ROSENBLATT, MARK I · 2017 to 2020
$1.6M
NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY027912
6 · The paper itself

Abstract

Axon guidance proteins have been found to play a regenerative role in the peripheral nervous system and the cornea. Netrin-4 is a member of the Netrins family of axon guidance proteins implicated in diabetic retinopathy and corneal hemangiogenesis. However, its effects on corneal nerve and epithelium repair are not well understood. We performed in vitro and in vivo studies to assess the effects of Netrin-4 in corneal wound healing. We found that Netrin-4 induced extensive neurite growth and branching in trigeminal ganglia neurons and accelerated the scratch closure of corneal epithelial cells. In vivo, the dual action of Netrin-4 enhanced corneal epithelium healing and nerve regeneration in mice subjected to corneal epithelium debridement. Inhibition studies demonstrate that Netrin-4-induced neuronal growth may be mediated by interaction with Neogenin or α6β1 Integrin receptors. In conclusion, our data demonstrate that Netrin-4 has trophic and neuroregenerative effects in the cornea and could be a suitable therapeutic target to treat corneal injury.

Indexed as

axon guidance proteinscornea wound healingnerve regenerationNetrin‐4

Identifiers

PMID40496349
PMCPMC12147499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.